MV Capital Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.6K Sell
51
-27
-35% -$1.46K ﹤0.01% 707
2026
Q1
$4.08K Buy
78
+1
+1% +$60 ﹤0.01% 650
2025
Q4
$4.53K Hold
77
﹤0.01% 619
2025
Q3
$4.28K Buy
77
+18
+31% +$964 ﹤0.01% 625
2025
Q2
$3.04K Sell
59
-82
-58% -$4.12K ﹤0.01% 662
2025
Q1
$8.27K Sell
141
-5
-3% -$339 ﹤0.01% 544
2024
Q4
$10.5K Buy
146
+8
+6% +$587 ﹤0.01% 512
2024
Q3
$11K Sell
138
-4
-3% -$301 ﹤0.01% 514
2024
Q2
$10.2K Sell
142
-7
-5% -$515 ﹤0.01% 517
2024
Q1
$10.5K Sell
149
-3
-2% -$215 ﹤0.01% 517
2023
Q4
$11.7K Buy
152
+14
+10% +$922 ﹤0.01% 502
2023
Q3
$9.39K Hold
138
﹤0.01% 511
2023
Q2
$11.3K Buy
138
+8
+6% +$643 ﹤0.01% 487
2023
Q1
$9.64K Buy
130
+106
+442% +$8.17K ﹤0.01% 515
2022
Q4
$1.99K Buy
24
+16
+200% +$1.27K ﹤0.01% 613
2022
Q3
$1K Buy
+8
New +$691 ﹤0.01% 669
2022
Q2
Sell
-36
Closed -$4K 712
2022
Q1
$4K Buy
36
+24
+200% +$2.48K ﹤0.01% 622
2021
Q4
$2K Sell
12
-20
-63% -$2.45K ﹤0.01% 663
2021
Q3
$4K Buy
+32
New +$3.89K ﹤0.01% 625
2017
Q1
Sell
-440
Closed -$11K 380
2016
Q4
$11K Hold
440
﹤0.01% 229
2016
Q3
$12K Hold
440
﹤0.01% 214
2016
Q2
$12K Hold
440
﹤0.01% 215
2016
Q1
$10K Hold
440
﹤0.01% 223
2015
Q4
$10K Hold
440
﹤0.01% 236
2015
Q3
$10K Hold
440
﹤0.01% 224
2015
Q2
$11K Hold
440
﹤0.01% 296
2015
Q1
$11K Hold
440
﹤0.01% 283
2014
Q4
$10K Buy
+440
New +$10.1K ﹤0.01% 292

Other funds holding TECH

MV Capital Management's TECH Position: Q2 2026 in Review

MV Capital Management reduced its Bio-Techne (TECH) stake by 35% in Q2 2026, selling an estimated $1.46K and leaving 51 shares worth $3.6K. The position accounts for ﹤0.01% of the portfolio, ranked #707.

MV Capital Management first reported a position in TECH in Q4 2014 and has held it in 28 quarters since. The position peaked at $12K in Q3 2016. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • MV Capital Management held 51 shares of Bio-Techne worth $3.6K as of Q2 2026.
  • MV Capital Management sold 27 Bio-Techne shares in Q2 2026, an estimated $1.46K.
  • Bio-Techne made up ﹤0.01% of MV Capital Management's portfolio in Q2 2026, its #707 holding.
  • MV Capital Management first reported a position in Bio-Techne in Q4 2014 and has held it in 28 quarters since.
  • MV Capital Management's Bio-Techne position peaked at $12K in Q3 2016.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.